Prototheca wickerhamii is a rare cause of systemic infection in humans. While some cases occur in previously healthy individuals, others are associated with a variety of preexisting diseases. Here we present, for the first time, a case of P. wickerhamii algaemia in a patient with myasthenia gravis. The patient was successfully treated with amphotericin B.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC230169PMC
http://dx.doi.org/10.1128/jcm.35.12.3305-3307.1997DOI Listing

Publication Analysis

Top Keywords

prototheca wickerhamii
8
patient myasthenia
8
myasthenia gravis
8
algaemia prototheca
4
wickerhamii patient
4
gravis prototheca
4
wickerhamii rare
4
rare systemic
4
systemic infection
4
infection humans
4

Similar Publications

are ubiquitous algae and occasional pathogens of humans and animals. While rare, the infection is often fatal and treatment options are limited to antifungals with low efficiency. Here, using growth curve assays, we demonstrate that five pathogenic species of () were fully inhibited by 50-100 μg/mL of herbicide glyphosate, suggesting novel pathways that can be considered for anti-algal drug development.

View Article and Find Full Text PDF

Disseminated protothecosis in a dog coinfected with Hepatozoon canis and Ehrlichia canis.

Vet Res Commun

January 2025

Facultad de Ciencias Veterinarias. Cátedra de Enfermedades Infecciosas, Universidad de Buenos Aires, Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina.

Protothecosis is a severe, emerging opportunistic infection caused by the saprophytic, achlorophyllous microalgae of the genus Prototheca. Though uncommon, human and animal cases are increasing worldwide, making awareness of this fungal-like pathogen important in both human and veterinary medicine. We report a fatal case of disseminated protothecosis caused by P.

View Article and Find Full Text PDF

Background: Protothecosis in dogs is a rare, yet emerging disease, distinguished by its often-aggressive clinical course and high fatality rate. Our study was conducted to enhance treatment protocols for affected dogs by better understanding the genetic diversity and drug resistance patterns of Prototheca species.

Objectives: To identify species and drug susceptibility profiles of an international collection of 28 Prototheca strains isolated from cases of protothecosis in dogs.

View Article and Find Full Text PDF

Phenotypic and molecular characterization of Prototheca wickerhamii from a Brazilian case of human systemic protothecosis.

PLoS Negl Trop Dis

November 2024

Departamento de Análises Clínicas e Toxicológicas, Faculdade de Farmácia, Universidade Federal de Minas Gerais, Brazil.

Article Synopsis
  • The genus Prototheca consists of non-chlorophyll algae that can be harmful to mammals, particularly affecting immunocompromised individuals.
  • Researchers studied a case of protothecosis in an HIV patient, identifying the organism as Prototheca wickerhamii through both phenotypic and molecular methods.
  • This case marks the first reported instance of systemic human protothecosis in Brazil and emphasizes the need for new detection methods for pathogenic algae in medical settings.
View Article and Find Full Text PDF

is an opportunistic pathogen that can infect both humans and animals, of which () being the most significant pathogenic green algae. The incidence of human diseases caused by has been on the rise, yet there is a significant gap in genetic research pertaining to the pathophysiological aspects of these infections. The aim of this study is to present the whole genome data from the clinical isolate InPu-22_FZ strain and to understand its genomic characteristics through comparative genomic analysis and phylogenetic tree analysis.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!